Header cover image

Pharmaceuticals & Biotech Managed Healthcare

Results

253

0 new

US companies operating in the health insurance space

253 companies

CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

A199800

ToolGen
₩54,300.00-3.6%62.3%₩431.4bn/aPS403.1xn/an/a

A206650

EuBiologics
₩11,770.001.9%11.9%₩430.0b₩15,000.00PS6.2xE66.3%n/a

A372320

Curocell
₩29,750.000.2%n/a₩419.2bn/an/an/an/a

A249420

Ildong Pharmaceutical
₩14,320.002.7%-31.8%₩400.0b₩25,000.00PB2.4xE71.8%0%

A215600

SillaJen
₩2,860.000.7%-42.1%₩392.9bn/aPS237.1xn/an/a

A256840

BNC Korea
₩5,890.004.2%54.4%₩391.4bn/aPE18.3xn/an/a

A228760

Genomictree
₩16,290.00-5.2%-21.3%₩390.7bn/aPS191.7xE107.8%n/a

A084110

Huons Global
₩31,550.009.0%39.6%₩385.4bn/aPE8.6xn/a1.7%

A334970

Prestige Biologics
₩6,090.00-3.6%30.5%₩374.5bn/aPS214.5xn/an/a

A047920

HLB Pharmaceutical
₩26,600.00-1.7%106.2%₩373.5bn/an/an/an/a

A200670

Humedix
₩35,450.00-2.3%-2.9%₩368.5b₩54,000.00n/aE24.3%1.6%

A003000

Bukwang Pharmaceutical
₩5,190.003.4%-16.4%₩355.3bn/aPS3xn/a0%

A243070

Huons
₩29,100.001.2%-33.4%₩344.8bn/aPE8.6xE15.3%2.3%

A000520

Samil PharmaceuticalLtd
₩15,800.0013.7%125.7%₩333.9bn/aPS1.6xn/a0%

A005690

Pharmicell
₩5,490.001.1%-24.0%₩329.4bn/an/an/an/a

A323990

Vaxcell-Bio Therapeutics
₩14,290.00-0.07%-37.9%₩328.6bn/aPS4720.9xn/an/a

A226950

OliX Pharmaceuticals
₩18,970.001.6%18.2%₩322.0bn/aPS18xn/an/a

A003220

Daewon Pharmaceutical
₩15,000.002.5%-8.0%₩321.5b₩21,000.00PE21.9xE35.6%2.0%

A033270

Korea United Pharm
₩21,850.000.2%-17.4%₩321.4bn/an/an/a1.9%

A445680

Curiox Biosystems
₩19,630.00-4.9%-10.7%₩315.4bn/aPS55.4xn/an/a

A216080

JETEMA
₩17,000.004.6%-24.4%₩303.6b₩28,000.00PE15xE35.3%n/a

A058820

CMG Pharmaceutical
₩2,180.00-1.1%-6.4%₩302.8bn/aPE36.6xn/an/a

A001630

Chong Kun Dang Holdings
₩60,000.002.4%11.5%₩285.6bn/aPE5.9xn/a2.3%

A041960

Komipharm International
₩4,060.003.6%-27.2%₩282.8bn/aPE82.4xn/an/a
Page 3 of 11
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.